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Background: Nearly 1 in 5 people living with HIV in the United States are unaware they are infected. Therefore, it is
important to develop and evaluate health communication messages that clinicians can use to encourage HIV testing.
Methods: The objective was to evaluate health communication messages designed to increase HIV testing rates
among women and evaluate possible moderators of message effect. We used a randomized four-arm clinical trial
conducted at urban community outpatient health clinics involving 1,919 female patients, 18 to 64 years old. The four
health message intervention groups were: i) information-only control; ii) one-sided message describing the advantages
of HIV testing; iii) two-sided message acknowledging a superficial objection to testing (i.e., a 20 minute wait for results)
followed by a description of the advantages of testing; and iv) two-sided message acknowledging a serious objection
(i.e., fear of testing positive for HIV) followed by a description of the advantages of testing. The main outcome was
acceptance of an oral rapid HIV test.
Results: Participants were randomized to receive the control message (n = 483), one-sided message (n = 480), two-sided
message with a superficial objection (n = 481), or two-sided message with a serious objection (n = 475). The overall
rate of HIV test acceptance was 83%. The two-sided message groups were not significantly different from the controls.
The one-sided message group, however, had a lower rate of testing (80%) than the controls (86%) (OR, 0.66; 95% CI,
0.47–0.93; P = 0.018). “Perceived obstacles to HIV testing” moderated this effect, indicating that the decrease in HIV test
acceptance for the one-sided message group was only statistically significant for those who had reported high levels
of obstacles to HIV testing (OR, 0.36; 95% CI, 0.19–0.67; P = 0.001).
Conclusions: None of the messages increased test acceptance. The one-sided message decreased acceptance and
this effect was particularly true for women with greater perceived obstacles to testing, the very group one would
most want to persuade. This finding suggests that efforts to persuade those who are reluctant to get tested, in some
circumstances, may have unanticipated negative effects. Other approaches to messaging around HIV testing should be
investigated, particularly with diverse, behaviorally high-risk populations.
Trial registration: Clinicaltrials.gov Identifier: NCT00771537. Registration date: October 10. 2008
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The Centers for Disease Control and Prevention (CDC)
estimate that there are nearly 1.1 million people living
with HIV in the United States today and that nearly 1 in
5 are unaware they are infected [1]. This situation may
be explained by a recent report published by the CDC,
which indicated that only 45% of adults in the United* Correspondence: mlkastin@iupui.edu
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unless otherwise stated.States have ever been tested for HIV and only 10% to
12% of those had been tested in the last 12 months [2,3].
Higher rates of testing will have to be achieved in order
to meet the U.S. Department of Health and Human
Services Healthy People 2020 goal of increasing the
percentage of HIV-infected persons who know that they
are infected from 80.9% to 90% [4]. Early detection of
HIV is critical for initiation of treatment to prevent pro-
gression to AIDS and for effective viral suppression [5].
Furthermore, people who are aware of their HIV status
are more likely to reduce their risky sexual behaviorsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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partners [6]. Thus, it is important to evaluate interven-
tions, including health messaging, designed to increase
rates of HIV testing.
When recommending a health behavior, one can employ
either a one-sided or a two-sided message. A one-sided
message presents only arguments supportive of the advo-
cated behavior or position. A two-sided message provides
supporting arguments, but also acknowledges (and usually
rebuts) one or more potential arguments against the advo-
cated behavior. The instinct of most health professionals
is to stress the benefits of the behavior they are advo-
cating; as a consequence, the vast majority of persuasive
messages (e.g., advertisements) are one-sided [7]. How-
ever, seminal studies by Hovland et al. found that two-
sided messages are sometimes more persuasive than
one-sided messages [8]. The persuasive superiority of
two-sided messages may be more likely to hold if the
audience is resistant to persuasion (i.e., holds negative
prior attitudes toward the advocated behavior) [7].
The principal theory addressed in this study is Inocu-
lation Theory, which is said to increase the effectiveness
of a two-sided message [9]. Inoculation Theory holds
that a two-sided message works in much the same way
as vaccination; that is, by exposing subjects to a weakened
(e.g., rebutted) form of a negative argument. Subjects
are believed to be less likely to raise mental “counter-
arguments” during message processing than if they had
just heard a one-sided message, theoretically leading to
increased message acceptance [10-12]. However, it is
important to note that Inoculation Theory suggests the
effects of a two-sided message may be less effective
than a one-sided message if it raises negative arguments
that would not otherwise have occurred to the audience.
As a result, for some individuals and in some circum-
stances, a two-sided message may lead to a boomerang
effect (i.e., create more negative attitudes than existed
prior to message exposure). Furthermore, without the
“inoculating” effect of the two-sided message, a one-
sided message is likely to generate counter-arguments
among resistant audience members (e.g., those who
have high perceived barriers to testing), and these counter-
arguments may be more persuasive than the message itself,
also causing a boomerang effect.
Our objective was to evaluate one-sided and two-sided
health communication messages designed to overcome
attitudinal barriers with the goal of increasing HIV testing
rates among women, who continue to be a significantly
underrepresented population in HIV-related research
[13]. In addition to evaluating the effects of message
sidedness, we were also interested in assessing whether any
significant effects of the intervention might vary (i.e., be
moderated by) at different levels of socio-demographic
factors (age, race/ethnicity, education, income, relationshipstatus, employment status), sexual behavior (total number




Eligible participants for this study were women who were
18 years of age and older, able to understand English or
Spanish, HIV-negative (via self-report), non-pregnant,
and seeking clinical services at one of seven urban
community health clinics located in Indianapolis, IN,
USA. All recruitment sites were full-service health clinics
that offered a range of diagnostic and treatment services.
Patient demographics varied among the seven different
clinic sites with some being fairly equally distributed
across Hispanic, non-Hispanic black, and non-Hispanic
white while others had higher proportions of either black
or white. For the purpose of our study, we oversampled
ethnic minorities so that we could assess potential differ-
ences in the effects of messaging across different races/
ethnicities. Questions, information, and the interventions
were presented to the participants one time via audio
computer-assisted self-interview (ACASI), so high levels
of literacy were not required, and participants only had to
be able to recognize individual numbers and letters to
indicate their responses. Surveys were completed in a
private room and it took each participant an average of
20 minutes to complete the survey. Pregnant women
(by self-report) were excluded because HIV testing is
routinely recommended and provided to all women
who are pregnant.
The study was approved by the Indiana University
Institutional Review Board and data were collected
from August 2008 to January 2011. Potential partici-
pants were recruited from clinic waiting rooms, but all
consent and study procedures took place in a private
area. All participants provided written informed consent
and were compensated with a $25 gift card for the time
and effort involved in completing the ACASI. Individuals
who met the inclusion criteria and agreed to participate
were oriented to the ACASI by the project manager.
Throughout the ACASI process the project manager
remained available for questions or problems, but did not
directly supervise the ACASI.
Study design
This study followed a four-group parallel design with
balanced randomization across four message groups. We
randomized adult women into the following groups: i)
an information-only control condition; ii) a one-sided
message advocating HIV testing; iii) a two-sided message
acknowledging and refuting a superficial objection; and
iv) a two-sided message acknowledging and refuting a
more serious objection. Individuals in the control group
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about the rapid HIV test being offered (this information
was provided to all four arms). The one-sided group saw
and heard messages describing only the benefits of HIV
testing (e.g., “If you detect HIV early, you can get treat-
ments that can greatly improve your long term health”).
The two-sided superficial message involved description
of a relatively minor objection to testing (e.g., “Some
people may not get tested because they think it is incon-
venient to wait 20 minutes to get the result”), followed
by refutation of the objection and the message noting
the benefits of testing. The two-sided serious message
involved a more substantial objection to testing (e.g.,
“Some people do not get tested for HIV because they
are afraid that they will find out that they have HIV
infection”) followed by refutation of the objection and the
message noting the benefits of testing. By preemptively
presenting objections to testing, along with refutations
of the objections, Inoculation Theory would predict a
decrease in resistance to getting tested for HIV. The
messages were developed from qualitative interviews
conducted during a pilot study for this project. The ser-
ious objection was determined from these qualitative
interviews carried out at the same clinics used toTable 1 Intervention messages
Intervention messages
Control message One-sided message Two
a su
The HIV test tells you if you are
infected with HIV, the virus which
can cause AIDS. AIDS destroys
your body’s ability to fight illness.
The HIV test tells you if you are
infected with HIV, the virus which
can cause AIDS. AIDS destroys





If you get the HIV test, we take a
swab of saliva from your mouth,






If you get the HIV test, we take
a swab of saliva from your mouth,
and in about 20 minutes you
get the results.
There are many benefits of







– If you detect HIV early, you can
get treatments that can greatly




– If you know you have HIV, you





– If you are thinking about
getting pregnant, you can get





– If the test shows you don’t have





haconduct the surveys [14]. Wait time was not identified
as a serious objection by participants in the qualitative
study so we determined that it was a good representation
of a superficial barrier. Table 1 shows the full text of the
four messaging conditions. Using a computer-generated
random number algorithm, participants were randomized
within the ACASI program in blocks of 64 to one of the
four health message conditions. Across each sequential
group of 64 participants, 16 would be assigned to each
study arm with a 1:1:1:1 allocation ratio. Both research
staff and participants were blinded to the intervention.
Measures and interventions
The ACASI measured socio-demographic factors (age,
sex, education, race, employment status, relationship
status, and family income). In addition, we assessed
potential attitudinal moderators of framing effects with
three scales: perceived obstacles to testing, perceived
benefits of testing, and normative beliefs about testing.
These health beliefs were adapted from previous research
on other medical diagnostic tests and vaccine acceptance
studies [15-17]. They were assessed with items that used a
5-point Likert-type response scale ranging from ‘Strongly




HIV test tells you if you are
ted with HIV, the virus which
cause AIDS. AIDS destroys your
y’s ability to fight illness.
The HIV test tells you if you are
infected with HIV, the virus which
can cause AIDS. AIDS destroys
your body’s ability to fight illness.
u get the HIV test, we take
ab of saliva from your mouth,
in about 20 minutes you
the result.
If you get the HIV test, we take a
swab of saliva from your mouth,
and in about 20 minutes you
get the result.
e are some reasons that people
for not getting the HIV test.
example, some people may
get tested because they think
inconvenient to wait 20 minutes
et the result.
There are some reasons that people
give for not getting the HIV test. Some
people do not get tested for HIV
because they are afraid that they will
find out that they have HIV infection.
20 minutes is a fairly short
to wait and there are many
fits of getting the HIV test:
But there are many benefits of
getting the HIV test and finding
out your results:
you detect HIV early, you can
t treatments that can greatly
prove your long term health.
– If you detect HIV early, you can
get treatments that can greatly
improve your long term health.
you know you have HIV,
u can do things to protect
e ones you love.
– If you know you have HIV,
you can do things to protect
the ones you love.
you are thinking about getting
egnant, you can get treatments
protect the baby from HIV.
– If you are thinking about getting
pregnant, you can get treatments
to protect the baby from HIV.
the test shows you don’t
ve HIV, you will feel relieved.
– If the test shows you don’t
have HIV, you will feel relieved.
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think of a lot of reasons not to get tested for HIV”).
Perceived benefits of testing was assessed with five
items (e.g., “Getting tested for HIV/AIDS would be a
good way to protect my health”) and had good internal
reliability (coefficient alpha = 0.81). Normative beliefs
about testing were assessed with six items (e.g., “Most
of the people I know think that getting tested for HIV/
AIDS is a good thing to do for your health”) and had a
good internal reliability (alpha coefficient = 0.76).
Outcome
The outcome of interest was HIV test acceptance. At the
conclusion of the survey, participants were offered free
oral fluid rapid HIV testing (Oraquick® Test by OraSure
Technologies, Inc., Bethlehem, PA, USA). Test accept-
ance was measured as a binary yes/no variable.
Statistical analysis
The data were analyzed using logistic regression, with
the control message serving as the reference level. First,
we analyzed the main effect of the intervention on HIV
testing rates. We planned to further analyze any signifi-
cant main effects with a series of moderation analyses.
These analyses were performed in order to determineFigure 1 Flowchart of the study.whether the identified main effect might vary based on
subgroups. Potential moderators were age, education, race/
ethnicity, employment status, number of lifetime partners,
perceived benefits, perceived norms, or perceived obstacles.
For the moderation analyses, the designated moderator
was added as a predictor, as well as the interaction between
the moderator and message type. Any statistically signifi-
cant moderator analyses (i.e., those that had a statistically
significant interaction with message type) were further
explored by doing separate logistic regression analyses,
stratified by levels of the moderator in order to examine
the specific nature of the moderation.
Power calculations
We enrolled 1,919 participants in the main portion of
the study or approximately 480 per experimental condi-
tion. Testing acceptance in the control group was 86%.
Based on a logistic regression model with a two-tailed
5% significance level, we had 88% power to detect a linear
effect with a 2% increase with each successive group, i.e.,
92% acceptance in the best (expected to be two-sided
major objection) message group. For an intervention
effect that is not linear, we would still have 93% power
to detect a main effect if the groups were evenly spread
between 86% and 93.5% acceptance. The main contrasts
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and the intervention groups. We estimated that there was
80% power to detect a 5.7% difference.
Results
Sample description
A total of 6,763 women were screened for eligibility and
2,148 were ultimately randomized to the four messaging
conditions. Computer and electronic survey failures led
to the loss of data from 113 participants (5.3%). In light
of the CDC’s recommendation for routine opt-out testing
for individuals aged 13 to 64, for this paper we excluded
women who were aged 65 years and older (n = 116),
resulting in a final sample of 1,919 (Figure 1) [18]a. These
women were 18 to 64 years of age (mean = 42.7), 20%







Mean age 42.7 42.9 42.9
Education
<High school 28% 30% 29%
High school graduate 32% 29% 31%
>High school education 41% 41% 40%
Race
Hispanic 20% 18% 18%
Non-Hispanic Black 44% 45% 43%
Non-Hispanic White/Other 36% 37% 39%
Employment status
Currently employed 40% 38% 39%
Currently unemployed 60% 62% 61%
Relationship status
Married and living with husband 36% 37% 33%
Married and not living with husband 10% 12% 9%
Not married and living with partner 32% 31% 33%
Not married and not living with partner 23% 20% 26%
Lifetime sexual partners
<5 35% 35% 35%
5–10 36% 37% 35%
>10 30% 28% 29%
Annual family income
<$10,000 47% 47% 47%
$10,000–$29,999 42% 45% 40%
≥$30,000 12% 9% 13%
Perceived obstacles
Low obstacles 73% 74% 75%
High obstacles 27% 26% 25%and 36% identified as non-Latina White/Other. Race
was assessed by self-report; Table 2 shows the complete
description of socio-demographic characteristics. As shown
in Figure 1, participants were distributed fairly equally
across intervention conditions and a randomization check
indicated that there were no statistically significant differ-
ences at baseline across conditions (see columns 2–6 of
Table 2). Overall, of the 1,919 participants, 83% accepted
the HIV test. Among the women who accepted the HIV
test, there was one Western Blot confirmed true positive
and one false positive.
HIV test acceptance
The highest rate of testing (86%) occurred among partic-
ipants in the control group, who received no persuasive





objection (n = 481)
Two-sided message
with serious
































Table 3 Analysis of messaging effects on HIV testing stratified by level of perceived obstacles
Low obstacles High obstacles
Percentage accepting
HIV test
OR (95% CI) P value Percentage accepting
HIV test
OR (95% CI) P value
Intervention:
Control 86.7% n/a 85.4% n/a
One-sided 84.6% 0.84 (0.55–1.28) 0.427 67.5% 0.36 (0.19–0.67)* 0001*
Two-sided with superficial objection 83.1% 0.76 (0.50–1.15) 0.187 77.1% 0.58 (0.31–1.09) 0.092
Two-sided with serious objection 86.0% 0.94 (0.61–1.50) 0.782 83.8% 0.89 (0.45–1.76) 0.738
*Statistically significant.
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and 82%, respectively) differed significantly from the
control group (86%) in acceptance of HIV testing. How-
ever, the one-sided message group had significantly
lower rates of testing (80%) than the control group
(86%) (OR, 0.66; 95% CI, 0.47–0.93; P = 0.018).
Moderator analyses
Of the eight potential moderators, only the interaction
between the intervention and “perceived obstacles to
testing” was statistically significant (P = 0.048). Specific-
ally, compared to the control condition, the one-sided
message resulted in lower rates of test acceptance with
increases in perceived obstacles (OR, 0.70; 95% CI, 0.53–
0.93; P = 0.013). To further explain this moderator
effect, we dichotomized the sample based on perceived
obstacles: low obstacles (i.e., responses of “Strongly
Disagree” and “Disagree”) and high obstacles (i.e., re-
sponses of “Neither Agree nor Disagree”, “Agree”, and
“Strongly Agree”). Logistic regression analyses stratified
by level of perceived obstacles indicated no significant
























Figure 2 Moderating effect of perceived obstacles by test acceptance
Perceived Obstacles groups (P = .001).group, but significantly lower rates of testing with the
one-sided message for the “high perceived obstacles”
group (OR, 0.36; 95% CI, 0.19–0.67; P = 0.001). Table 3
shows the full results of the stratification analysis.
Figure 2 shows a graphical representation of the mo-
derating effect of the intervention on test acceptance
between those with low and high obstacles.Discussion
In this study, the women who received either of the two-
sided messages did not have HIV testing rates that were
significantly higher than those who received information
only. Surprisingly, the one-sided message had negative
effects on test acceptance, particularly for those women
who came into the study perceiving high obstacles to
HIV testing. This finding is particularly noteworthy, in
that it suggests that efforts at direct persuasion may have
the unanticipated effect of discouraging acceptance of
HIV testing, particularly among those individuals one
would most want to persuade (i.e., those who are reluc-
tant to get tested). Yet, many HIV testing brochures2-Sided Superficial 2-Sided Serious
High Obstacles
. *Significant difference in HIV test acceptance between Low and High
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largely one-sided approach to health messaging about
HIV testing [19-22].
The unanticipated negative effect or “boomerang effect”
of the one-sided message that was identified in this study
has been described in previous literature on message
framing and mammography screening [23,24], suggesting
that health messaging interventions need to be carefully
evaluated and compared to a control condition. If we
had simply tested one-sided vs. two-sided messages, for
instance, without an information-only control group,
we would not have identified the negative impact of the
one-sided condition. Overall, reactance reduced test
acceptance by 6%, which is a modest effect size, but
meaningful when extrapolated across a large popula-
tion. However, it is notable that for the high perceived
obstacles group, the one-sided message had a very large
effect size and reduced test acceptance by nearly 18
percentage points (85.4% vs. 67.5%).
There are a number of limitations to this study which
may limit generalizability and suggests that the results
should be interpreted with some caution. First, we had a
relatively high rate of test acceptance across groups,
indicating that a ceiling effect may have limited our abil-
ity to increase testing rates with simple health messages.
It is possible that two-sided messages might work more
effectively in populations with lower base rates of test
acceptance. Also, although the study sample was racially/
ethnically diverse, it was composed only of women attend-
ing clinics in Indianapolis. Moreover, although there was a
relatively low participation rate among those screened
for eligibility (just over 30%), most of the women who
declined did so due to a lack of time, not due to objec-
tions about the nature of the study. It is possible that
there was a self-selection bias with this study and the
participants who were willing to participate in the study
were also more willing to get tested for HIV. Furthermore,
males, people with differing levels of perceived vulnerabil-
ity, and those from other geographic locations may re-
spond differently to HIV test messages. A recent study,
for instance, found that men and women responded in op-
posite directions to two-sided messages related to news
coverage [25]. In another study, induction of mortality sa-
lience increased rates of HIV testing, but only among
those who were exposed to a message that increased their
feelings of vulnerability to HIV. Mortality salience among
participants in the low vulnerability condition resulted in
lower rates of testing [26]. It is possible that a brief inter-
vention such as this may work in a population where HIV
test acceptance is low. In order to increase test acceptance
beyond the already high rate identified in this study
may require a more in-depth intervention derived from
theories of behavior change such as Social Cognitive
Theory [27,28].Conclusions
To our knowledge, this is among the first randomized
clinical trials examining the effect of persuasive health
messages on HIV test acceptance in a clinical setting.
We found high rates of test acceptance across health
messaging conditions, but no increased testing rates in
the intervention groups. In fact, the one-sided persuasive
message unexpectedly led to decreased acceptance of
testing compared to an information-only control group.
This finding suggests that certain approaches to health
messaging, commonly used in clinical practice, can actu-
ally undermine efforts to maximize rates of HIV testing,
particularly among those who express reluctance to get
tested. Further research is needed to identify effective
health messaging and to evaluate messages in diverse
populations.
Endnote
aWhen women over 65 were included, the results were
the same.
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